Graves' orbitopathy (GO) is a potential concomitant autoimmune disorder in patients with Graves' disease (GD) which primarily targets the orbits by autoimmune processes leading to increased local formation of adipocytes. 1 Its incidence is age-related between 1-27/10.000/year with a peak between ages of 40 and 60 years. The prevalence is 10/10.000/year in Europe. 2 GO can consequently result in several optical sensations like diplopy, dry eye syndrome or exophthalmos and can affect the optical